Showing results (31-40 of 134) with videos related to
Sort By:
Pageof 14
Microorganisms|January 21, 2022
What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related DiseasesJulita Tokarek, Joanna Gadzinowska, Ewelina Młynarska, et al.International Journal of Molecular Sciences|December 23, 2022
The Role of Inflammation and Oxidative Stress in Rheumatic Heart DiseaseBeata Franczyk, Anna Gluba-Brzózka, Magdalena Rysz-Górzyńska, et al.International Journal of Molecular Sciences|December 11, 2022
Structural and Functional Changes in Aging KidneysJill Dybiec, Magdalena Szlagor, Ewelina Młynarska, et al.International Journal of Molecular Sciences|July 9, 2022
Are Alterations in DNA Methylation Related to CKD Development?Jacek Rysz, Beata Franczyk, Magdalena Rysz-Górzyńska, et al.Biomedicines|May 16, 2023
New Insights into the Use of Liraglutide-Impact on Cardiovascular Risk and Microvascular OutcomesMagdalena Wronka, Julia Krzemińska, Ewelina Młynarska, et al.Life (Basel, Switzerland)|August 27, 2021
High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk FactorsMałgorzata Koziarska-Rościszewska, Anna Gluba-Brzózka, Beata Franczyk, et al.Archives of Medical Science : AMS|January 28, 2015
Heart function disturbances in chronic kidney disease - echocardiographic indicesBeata Franczyk-Skóra, Anna Gluba, Robert Olszewski, et al.International Journal of Molecular Sciences|October 3, 2020
The Role of Metabolic Factors in Renal CancersJacek Rysz, Beata Franczyk, Janusz Ławiński, et al.Current Pharmaceutical Design|May 11, 2017
Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?Beata Franczyk, Anna Gluba-Brzózka, Piotr Bartnicki, et al.Current Pharmaceutical Design|March 18, 2017
The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular DiseaseJacek Rysz, Beata Franczyk, Robert Olszewski, et al.Pageof 14